Table 2.
Comparison of demographic and clinical characteristics of subjects with relation to ongoing pregnancy outcome in the fresh treatment cycle (n = 180)
| Median (range) | Ongoing pregnancy | P value | |
|---|---|---|---|
| Yes (n = 62) | No (n = 118) | ||
| Age (years) | 36 (27–41) | 37 (27–44) | 0.102 |
| Serum AMH (pmol/l) | 11.92 (1.50–94.96) | 8.53 (0.29–64.26) | 0.079 |
| Serum FSH (IU/l) | 6.0 (2.0–17.6) | 6.6 (1.6–13.3) | 0.466 |
| Day 6 serum estradiol (pmol/l) | 610 (73–3,171) | 463 (73–4,308) | 0.121 |
| Total dose of gonadotropin administered (IU) | 2,475 (1,200–4,200) | 2,700 (1,000–6,300) | 0.107 |
| Duration of stimulation (days) | 12 (9–19) | 12 (8–21) | 0.148 |
| No. of oocytes retrieved | 9 (2–21) | 7 (1–24) | 0.020a |
| No. of oocytes fertilized | 6 (1–17) | 5 (1–16) | 0.008a |
aStatistically significant (p < 0.05, Mann-Whitney U test)